Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Karam

Showing results (21-30 of 468) with videos related to

Pageof 47
Sort By:
European Urology|February 8, 2011
The dark side of targeted therapyJose A Karam, Christopher G Wood
The Journal of Urology|December 20, 2011
Editorial commentPatrick A Kenney, Jose A Karam
European Urology|March 14, 2012
The effects of temporary ischemia in partial nephrectomy on renal functional outcomes: how can effects best be estimated, and can they be mitigated?Jose A Karam, Christopher G Wood
The Journal of Urology|January 20, 2010
Editorial commentJose A Karam, Christopher G Wood
European Urology|February 27, 2013
Words of wisdom: re: prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trialsJose A Karam, Christopher G Wood
The Lancet. Oncology|April 1, 2008
Minimally invasive radical cystectomy for bladder cancer?Jose A Karam, Arthur I Sagalowsky
ITU Journal : ICT Discoveries|July 1, 2020
ANALYTIC MODELS FOR BISTATIC SCATTERING FROM A RANDOMLY ROUGH SURFACE WITH COMPLEX RELATIVE PERMITTIVITYMostafa A Karam, Ryan S McDonough
The New England Journal of Medicine|January 23, 2004
Images in clinical medicine. True hermaphroditismJose A Karam, Linda A Baker
Hematology/Oncology Clinics of North America|July 19, 2011
The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomyJose A Karam, Christopher G Wood
The Journal of Urology|November 21, 2015
Positive Margins after Radical Nephrectomy with Venous Thrombectomy: Controversies and Treatment OptionsJose A Karam, Surena F Matin
Pageof 47

Showing results (21-30 of 468) with videos related to

Sort By:
Pageof 47
European Urology|February 8, 2011
The dark side of targeted therapyJose A Karam, Christopher G Wood
The Journal of Urology|December 20, 2011
Editorial commentPatrick A Kenney, Jose A Karam
European Urology|March 14, 2012
The effects of temporary ischemia in partial nephrectomy on renal functional outcomes: how can effects best be estimated, and can they be mitigated?Jose A Karam, Christopher G Wood
The Journal of Urology|January 20, 2010
Editorial commentJose A Karam, Christopher G Wood
European Urology|February 27, 2013
Words of wisdom: re: prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trialsJose A Karam, Christopher G Wood
The Lancet. Oncology|April 1, 2008
Minimally invasive radical cystectomy for bladder cancer?Jose A Karam, Arthur I Sagalowsky
ITU Journal : ICT Discoveries|July 1, 2020
ANALYTIC MODELS FOR BISTATIC SCATTERING FROM A RANDOMLY ROUGH SURFACE WITH COMPLEX RELATIVE PERMITTIVITYMostafa A Karam, Ryan S McDonough
The New England Journal of Medicine|January 23, 2004
Images in clinical medicine. True hermaphroditismJose A Karam, Linda A Baker
Hematology/Oncology Clinics of North America|July 19, 2011
The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomyJose A Karam, Christopher G Wood
The Journal of Urology|November 21, 2015
Positive Margins after Radical Nephrectomy with Venous Thrombectomy: Controversies and Treatment OptionsJose A Karam, Surena F Matin
Pageof 47